Article: CLINICAL EVALUATION OF LEKHANIYA MAHAKASHAYA IN DYSLIPIDEMIA (MEDODUSHTI)

Article Category: Original Research articles

DOI: 10.7897/2277-4343.15373

Pages: 59-70

Author: Pratibha Bhatt *, DK Goyal

Abstract: Dyslipidemia is a metabolic imbalance that can result in a variety of diseases, including diabetes, hypertension, hypothyroidism, nephrotic syndrome, and others. The ailment of the era, Dyslipidemia, is primarily brought on by inadequate lifestyle choices. It has been wrongly overlooked for too long as a serious cardiovascular risk factor. According to ancient Ayurvedic texts, every single drug in the composition Lekhaniya Mahakashaya Ghanavati has been shown to have significant lipid-lowering properties. It is more closely related to Medodushti in Ayurveda, a functional illness that is only a precursor stage of Medoroga and is easily curable with the right regimen. Study design: The study was conducted on OPD and IPD patients at the Kayachikitsa department in the Gurukul Campus, Haridwar, Uttarakhand, India, for 50 days. A total of 40 patients in a single group were registered for the trial. It was a prospective, open, single-armed, randomised controlled trial. All of the patients received Lekhaniya Mahakashaya Ghanavati as an oral drug. Result and Discussion: An overall assessment of the drug was done based on the significance of the statistical tests. In the trial, 12.5% of patients had complete relief in signs and symptoms, marked improvement was found in 42.5%, and moderate improvement also accounted for 42.5% of the study population. The drug might be the treatment of choice for individuals with Dyslipidemia who are both diabetic and non-diabetic.

Keyword: Dyslipidemia, Medodushti, Lipids, Lekhaniya Mahakashaya Ghanavati